CGS-27023A analogs (Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCGS-27023A analogs (Novartis)
Drug Alias Nameelastase inhibitors (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-1 inhibitorsMatrix metalloproteinase 3 inhibitorsLeukocyte elastase inhibitors
TargetsMatrix metalloproteinase 3Matrix metalloproteinase-1Leukocyte elastase
Therapy Area/IndicationsEmphysemaRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsEmphysemaRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A